详情页 - 广东省中医院知识库

资源类型：

文章类型：

作者：

Hua Xing[1] * ; Liu Zhen[2] ; Zhou Min[3] ; Tian Yan[4] ; Zhao Pei-Pei[4] ; Pan Wen-Hai[1] ; Li Chao-Xia[1] ; Huang Xiao-Xiao[1] ; Liao Ze-Xiao[1] ; Xian Qi[1] ; Chen Bo[1] ; Hu Yue[1] ; Leng Lei[1] ; Fang Xiao-Wei[1] ; Yu Li-Na[4] ;

机构： [1]Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China. [2]Department of Pathology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, P.R. China. [3]Department of Otolaryngology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, P.R. China. [4]Department of pathology, School of Basic Medical Sciences, Southern Medical University, Guanghou 510515, P.R.China; Department of pathology, Nanfang Hospital, Guanghou 510515, P.R. China; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou 510515, P.R. China.

出处：

DOI：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 2 区医学

小类 | 2 区医学：研究与实验

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区医学：研究与实验

第一作者：

第一作者机构： [1]Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].

文献详情